These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15589001)

  • 21. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Janion M
    Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL; Safford RE; ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favorable long-term outcome of Maze surgery in patients with lone atrial fibrillation.
    Hemels ME; Gu YL; Tuinenburg AE; Boonstra PW; Wiesfeld AC; van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Ann Thorac Surg; 2006 May; 81(5):1773-9. PubMed ID: 16631671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboembolic complication in atrial fibrillation in a long-term follow-up--the relationship with underlying disease, type of atrial fibrillation, and antithrombotic therapy.
    Toda G; Akiyama K; Sakuragawa K; Iliev II; Hayano M; Yano K
    Jpn Circ J; 1998 Apr; 62(4):255-60. PubMed ID: 9583458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial.
    Goette A; Merino JL; De Caterina R; Huber K; Heidbuchel H; Jin J; Lip GYH
    Clin Res Cardiol; 2020 Nov; 109(11):1374-1380. PubMed ID: 32236718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Makowski M; Smorag I; Makowska J; Bissinger A; Grycewicz T; Paśnik J; Kidawa M; Lubiński A; Zielińska M; Baj Z
    Int J Cardiol; 2017 May; 235():1-5. PubMed ID: 28302320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study).
    Goette A; Lip GYH; Jin J; Heidbuchel H; Cohen AA; Ezekowitz M; Merino JL
    Am J Cardiol; 2020 Sep; 131():27-32. PubMed ID: 32753268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
    Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
    Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring.
    Weijs B; Limantoro I; Delhaas T; de Vos CB; Blaauw Y; Houben RPM; Verheule S; Pisters R; Crijns HJGM
    Clin Cardiol; 2018 Mar; 41(3):366-371. PubMed ID: 29569353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal timing for cardioversion in patients with atrial fibrillation.
    Hellman T; Kiviniemi T; Nuotio I; Biancari F; Vasankari T; Hartikainen J; Lehto M; Airaksinen KE;
    Clin Cardiol; 2018 Jul; 41(7):966-971. PubMed ID: 29802625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study.
    Grönefeld GC; Lilienthal J; Kuck KH; Hohnloser SH;
    Eur Heart J; 2003 Aug; 24(15):1430-6. PubMed ID: 12909072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Pison L; Hocini M; Potpara TS; Todd D; Chen J; Blomström-Lundqvist C;
    Europace; 2014 Oct; 16(10):1521-3. PubMed ID: 25267359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.
    Chiang CE; Naditch-Brûlé L; Murin J; Goethals M; Inoue H; O'Neill J; Silva-Cardoso J; Zharinov O; Gamra H; Alam S; Ponikowski P; Lewalter T; Rosenqvist M; Steg PG
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):632-9. PubMed ID: 22787011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lengthening of intraatrial conduction time in atrial fibrillation and its relation with early recurrence of atrial fibrillation.
    Akyürek O; Sayin T; Dinçer I; Karaoguz R; Güldal M; Oral D
    Jpn Heart J; 2001 Sep; 42(5):575-84. PubMed ID: 11804299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study.
    Brand FN; Abbott RD; Kannel WB; Wolf PA
    JAMA; 1985 Dec; 254(24):3449-53. PubMed ID: 4068186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.